As a result of the collapse of the financial markets and the challenges that has placed on their companies, total compensation for the chief executives at four of the five top mass-spec vendors — including salaries, stock options, bonuses, and other compensation — shrank last year, according to proxy statements filed recently with the US Securities and Exchange Commission.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.